[{"address1": "12770 High Bluff Drive", "address2": "Suite 150", "city": "San Diego", "state": "CA", "zip": "92130", "country": "United States", "phone": "619 949 3681", "website": "https://www.gyretx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Gyre Therapeutics, Inc., a pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis. The company offers ETUARY (Pirfenidone), an anti-fibrotic drug approved for the treatment of idiopathic pulmonary fibrosis; and under Phase 3 trials for the treatment of pneumoconiosis. It is also involved in the development of F351 (Hydronidone), a structural derivative of ETUARY, under Phase 3 trials for the treatment of chronic hepatitis B (CHB)-associated liver fibrosis; and completed Phase 1 trials for the treatment of liver fibrosis associated with metabolic dysfunction-associated steatohepatitis. In addition, the company develops F573 is in Phase 2 clinical trials for the treatment of acute/acute-on-chronic liver failure. Further, its preclinical products include F230 for the treatment of pulmonary arterial hypertension; and F528 to treat chronic obstructive pulmonary disease. The company was founded in 2002 and is headquartered in San Diego, California. Gyre Therapeutics, Inc. operates as a subsidiary of GNI USA, Inc.", "fullTimeEmployees": 579, "companyOfficers": [{"maxAge": 1, "name": "Mr. Songjiang  Ma", "age": 68, "title": "President & Director", "yearBorn": 1956, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Ruoyu  Chen", "age": 53, "title": "Chief Financial Officer", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 285000, "exercisedValue": 0, "unexercisedValue": 6744174}, {"maxAge": 1, "name": "Mr. Weiguo  Ye", "age": 46, "title": "Chief Operating Officer", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 332619, "exercisedValue": 0, "unexercisedValue": 18899056}, {"maxAge": 1, "name": "Dr. Han  Ying Ph.D.", "age": 59, "title": "Senior Vice President of Science", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 397945, "exercisedValue": 0, "unexercisedValue": 3216}, {"maxAge": 1, "name": "Mr. Ping  Zhang", "age": 51, "title": "Interim CEO & Executive Chair", "yearBorn": 1973, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 10, "compensationRisk": 8, "shareHolderRightsRisk": 7, "overallRisk": 9, "governanceEpochDate": 1761955200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 8.08, "open": 7.94, "dayLow": 7.8219, "dayHigh": 8.225, "regularMarketPreviousClose": 8.08, "regularMarketOpen": 7.94, "regularMarketDayLow": 7.8219, "regularMarketDayHigh": 8.225, "payoutRatio": 0.0, "beta": 7.11, "trailingPE": 199.75, "forwardPE": 17.369564, "volume": 63649, "regularMarketVolume": 63649, "averageVolume": 87354, "averageVolume10days": 56170, "averageDailyVolume10Day": 56170, "bid": 5.84, "ask": 10.24, "bidSize": 2, "askSize": 2, "marketCap": 778371904, "fiftyTwoWeekLow": 6.11, "fiftyTwoWeekHigh": 14.42, "allTimeHigh": 47990.25, "allTimeLow": 2.85, "priceToSalesTrailing12Months": 7.256532, "fiftyDayAverage": 7.7516, "twoHundredDayAverage": 8.6922, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 702825152, "profitMargins": 0.06201, "floatShares": 20523048, "sharesOutstanding": 96333157, "sharesShort": 1540111, "sharesShortPriorMonth": 1670982, "sharesShortPreviousMonthDate": 1759190400, "dateShortInterest": 1761868800, "sharesPercentSharesOut": 0.016, "heldPercentInsiders": 0.87101, "heldPercentInstitutions": 0.03434, "shortRatio": 18.49, "shortPercentOfFloat": 0.0743, "impliedSharesOutstanding": 97418261, "bookValue": 1.121, "priceToBook": 7.127564, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "earningsQuarterlyGrowth": 2.212, "netIncomeToCommon": 6651000, "trailingEps": 0.04, "forwardEps": 0.46, "lastSplitFactor": "1:15", "lastSplitDate": 1698710400, "enterpriseToRevenue": 6.552, "enterpriseToEbitda": 48.947, "52WeekChange": -0.36687797, "SandP52WeekChange": 0.14261019, "lastDividendValue": 3.6, "lastDividendDate": 1673568000, "quoteType": "EQUITY", "currentPrice": 7.99, "targetHighPrice": 20.0, "targetLowPrice": 16.0, "targetMeanPrice": 18.0, "targetMedianPrice": 18.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 60049000, "totalCashPerShare": 0.661, "ebitda": 14359000, "totalDebt": 1165000, "quickRatio": 5.414, "currentRatio": 6.195, "totalRevenue": 107265000, "debtToEquity": 0.848, "revenuePerShare": 1.227, "returnOnAssets": 0.052849997, "returnOnEquity": 0.10017, "grossProfits": 102415000, "freeCashflow": 2900250, "operatingCashflow": 3877000, "earningsGrowth": 1.662, "revenueGrowth": 0.199, "grossMargins": 0.95478, "ebitdaMargins": 0.13385999, "operatingMargins": 0.22660999, "financialCurrency": "USD", "symbol": "GYRE", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1144848600000, "postMarketChangePercent": 0.0, "postMarketPrice": 7.99, "postMarketChange": 0.0, "regularMarketChange": -0.0900002, "regularMarketDayRange": "7.8219 - 8.225", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 87354, "fiftyTwoWeekLowChange": 1.8799996, "fiftyTwoWeekLowChangePercent": 0.30769223, "fiftyTwoWeekRange": "6.11 - 14.42", "fiftyTwoWeekHighChange": -6.4300003, "fiftyTwoWeekHighChangePercent": -0.4459085, "fiftyTwoWeekChangePercent": -36.687798, "dividendDate": 1673481600, "earningsTimestamp": 1762522200, "earningsTimestampStart": 1762522200, "earningsTimestampEnd": 1762522200, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": 0.04, "epsForward": 0.46, "epsCurrentYear": 0.15, "priceEpsCurrentYear": 53.266663, "fiftyDayAverageChange": 0.23839998, "fiftyDayAverageChangePercent": 0.030754939, "twoHundredDayAverageChange": -0.70219994, "longName": "Gyre Therapeutics, Inc.", "twoHundredDayAverageChangePercent": -0.080785066, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.0 - Strong Buy", "cryptoTradeable": false, "regularMarketChangePercent": -1.11386, "regularMarketPrice": 7.99, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1763155200, "regularMarketTime": 1763154001, "exchange": "NCM", "messageBoardId": "finmb_100542295", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "shortName": "Gyre Therapeutics, Inc.", "displayName": "Gyre Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-11-15"}]